BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Dec 26, 2025; 17(12): 112978
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112978
Logistic regression-based risk prediction of aortic adverse remodeling following thoracic endovascular aortic repair in patients with aortic dissection
Lian-Feng Wang, Hong-Jiang Zhu, Cong Wang, Feng Yan, Chang-Zhen Qu
Lian-Feng Wang, Department of Oncology II, Zhangjiajie People's Hospital, Zhangjiajie 415000, Hunan Province, China
Hong-Jiang Zhu, Cong Wang, Feng Yan, Chang-Zhen Qu, Department of Vascular Interventional Surgery, Zhangjiajie People's Hospital, Zhangjiajie 415000, Hunan Province, China
Co-first authors: Lian-Feng Wang and Hong-Jiang Zhu.
Author contributions: Zhu HJ contributed to conceptualization, Formal analysis, Methodology, writing original draft, review and editing, project administration, supervision; Wang LF contributed to writing original draft, review and editing, project administration; Yan F contributed to visualization, writing original draft; Qu CZ contributed to data curation, investigation, review and editing; Wang C contributed to data curation, investigation.
Supported by Zhangjiajie "Xiao He (Young Talent)" Project, No. 2024XHRC03; and Jishou University School-Level Research Project.
Institutional review board statement: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee).
Informed consent statement: Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.
Conflict-of-interest statement: All authors declare that they have no conflicts of interest.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.
Data sharing statement: The data that support the findings of this study are not publicly available due to containing information that could compromise research participant privacy. However, data are available from the corresponding author Hong-Jiang Zhu upon reasonable request and with permission of the institutional review board/ethics committee.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Jiang Zhu, MD, Department of Vascular Interventional Surgery, Zhangjiajie People's Hospital, No. 192 Guyong Road, Yongding District, Zhangjiajie 415000, Hunan Province, China. 13028176178@163.com
Received: August 12, 2025
Revised: September 10, 2025
Accepted: November 6, 2025
Published online: December 26, 2025
Processing time: 135 Days and 1.5 Hours
Abstract
BACKGROUND

Aortic adverse remodeling remains a critical complication following thoracic endovascular aortic repair (TEVAR) for Stanford type B aortic dissection (TBAD), significantly impacting long-term survival. Accurate risk prediction is essential for optimized clinical management.

AIM

To develop and validate a logistic regression-based risk prediction model for aortic adverse remodeling following TEVAR in patients with TBAD.

METHODS

This retrospective observational cohort study analyzed 140 TBAD patients undergoing TEVAR at a tertiary center (2019–2024). Based on European guidelines, patients were categorized into adverse remodeling (aortic growth rate > 2.9 mm/year, n = 45) and favorable remodeling groups (n = 95). Comprehensive variables (clinical/imaging/surgical) were analyzed using multivariable logistic regression to develop a predictive model. Model performance was assessed via receiver operating characteristic-area under the curve (AUC) and Hosmer-Lemeshow tests.

RESULTS

Multivariable analysis identified several strong independent predictors of negative aortic remodeling. Larger false lumen diameter at the primary entry tear [odds ratio (OR): 1.561, 95%CI: 1.197–2.035; P = 0.001] and patency of the false lumen (OR: 5.639, 95%CI: 4.372-8.181; P = 0.004) were significant risk factors. False lumen involvement extending to the thoracoabdominal aorta was identified as the strongest predictor, significantly increasing the risk of adverse remodeling (OR: 11.751, 95%CI: 9.841-15.612; P = 0.001). Conversely, false lumen involvement confined to the thoracic aorta demonstrated a significant protective effect (OR: 0.925, 95%CI: 0.614–0.831; P = 0.015). The prediction model exhibited excellent discrimination (AUC = 0.968) and calibration (Hosmer-Lemeshow P = 0.824).

CONCLUSION

This validated risk prediction model identifies aortic adverse remodeling with high accuracy using routinely available clinical parameters. False lumen involvement thoracoabdominal aorta is the strongest predictor (11.751-fold increased risk). The tool enables preoperative risk stratification to guide tailored TEVAR strategies and improve long-term outcomes.

Keywords: Thoracic endovascular aortic repair; Aortic dissection; Adverse remodeling; Risk prediction model; False lumen; Thoracoabdominal involvement; Endovascular repair; Logistic regression

Core Tip: This study developed and validated a logistic regression-based risk prediction model for aortic adverse remodeling following thoracic endovascular aortic repair (TEVAR) in patients with type B aortic dissection. The model, incorporating routinely available clinical and imaging variables, demonstrated high predictive accuracy (area under the curve = 0.968). Pan-aortic false lumen involvement was identified as the strongest predictor, increasing the risk of adverse remodeling by nearly 12-fold. This tool facilitates preoperative risk stratification to guide personalized treatment strategies and improve long-term outcomes after TEVAR.